Henderson Behavioral Health (HBH) Selected to Participate in New US Centers for Medicare and Medicaid Services (CMS) Study to Improve Quality and Reduce Cost in Schizophrenia Care with New Technologies
Lauderdale Lakes, FL - Henderson is once again honored to be on the forefront of cutting-edge, research-based treatment thanks to its success in previous NIMH studies, most notably the Recovery After Initial Schizophrenic Episode, or RAISE study. That study began in January 2010 and evaluated the benefits of a comprehensive pharmacological and psychosocial treatment package for individuals with first episode psychosis, as compared to typical community mental health treatment (community care).
Remarking on this new project and latest national research project, Henderson CEO Dr. Steven Ronik said, "While providing evidence-based services is fundamental and we embrace that responsibility, we also feel an overwhelming obligation to contribute to the knowledge base-and we continue to do that with this critical research."
The goal of the Improve Care and Reduce Cost, or ICRC study, is to improve disease management and the overall process of care in treating schizophrenia in order to reduce ER visits and hospital days while providing better care and better health. This will be done by fostering innovation in the use of technology and by training and deploying Mental Health/Health Technology (MH/HT) Case Managers.
The components of the treatment model include: 1) evidence-based pharmacological treatment facilitated by a web-based prescriber decision support system 2) brief, in-person, relapse prevention counseling with supplemental web-based learning modules, 3) Technology to Extend Care and Support to Schizophrenia (TECSS), a program that offers web- and phone-based resources to support persons with schizophrenia and their family members, peers or others 4) an interactive smart phone application to support medication adherence, facilitate coping with symptoms and improve daily functioning in individuals with schizophrenia and 5) a web-based, self-administered cognitive-behavioral therapy (CBT) program for the management of hallucinations and paranoia.
HBH is one of only a few organizations nationwide that was selected by John Kane, M.D., at the Feinstein Institute's Center for Psychiatric Neuroscience, part of the North Shore-LIJ Health System in New York City. Dr. Kane is one of the nation's leading researchers in the area of schizophrenia.
This is the fourth national research project HBH has participated in since 2006, firmly establishing Henderson as an industry champion for the improvement of client care through evidenced-based, best practices treatment and research.
Founded 60 years ago to address the needs of our community, Henderson Behavioral Health, a CARF-Accredited not-for-profit organization, has provided behavioral health services to hundreds of thousands of children, adults and families throughout South Florida. Online at www.hendersonbehavioralhealth.org